Featured Post

Manual on meat inspection for developing countries

Image
lymph node tuberculosis spread :: Article Creator Deadly Diseases When German biologist and doctor Robert Koch announced in 1882 that he had discovered the bacterial cause of tuberculosis, he said, "If the number of victims which a disease claims is the measure of its significance, then all diseases … must rank far behind tuberculosis." By this measure, tuberculosis today still outranks most other infectious diseases for its sheer potential to affect vulnerable populations. The World Health Organization reports that TB infects one new person every second and is the world's leading killer of women. An ancient disease, tuberculosis has been found in the skulls and spinal cords of Egyptian mummies 3,000 years old. The Greek physician Hippocrates called "consumption" — as tuberculosis was often known in the past — the most common deadly disease of his time. An estimated one billion people died from tuberculosis between 1700

Pneumonia in Immunocompromised Patients: Overview, Causes of Pneumonia, HIV/AIDS



chronic obstructive pulmonary disease pulmonary rehabilitation :: Article Creator

Pulmonary Rehabilitation And Exercise Training In Chronic Obstructive Pulmonary Disease

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Report: Global strategy of the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2017; www.Goldcopd.Org (last accessed on 15 January 2018). 2. Rochester CL, Vogiatzis I, Holland AE, et al.: An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med 2015; 192: 1373–86 CrossRef MEDLINE 3. Spruit MA, Singh SJ, Garvey C, et al.: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13–64 CrossRef MEDLINE 4. Ries AL, Bauldoff GS, Carlin BW, et al.: Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007; 131: 4S–42S CrossRef MEDLINE 5. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2: CD003793 CrossRef 6. Kenn K, Gloeckl R, Soennichsen A, et al.: Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation. Transplantation 2015; 99: 1072–7 CrossRef MEDLINE 7. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J: Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011: CD005305 CrossRef 8. Gillissen A, Haidl P, Kohlhäufl M, Kroegel K, Voshaar T, Gessner C: The pharmacological treatment of chronic obstructive pulmonary disease. Dtsch Arztebl Int 2016; 113: 311–6 VOLLTEXT 9. Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T: Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016; 12: CD005305 CrossRef 10. Puhan MA: Managing an acute exacerbation of COPD: is pulmonary rehabilitation the solution? Abstract. Denver, Colorado (USA): Annual Meeting of the American Thoracic Society 2015. 11. Magnussen H, Kirsten AM, Kohler D, Morr H, Sitter H, Worth H:Guidelines for long-term oxygen therapy. German Society for Pneumology and Respiratory Medicine. Pneumologie 2008; 62: 748–56 CrossRef MEDLINE 12. Koehnlein T, Schonheit-Kenn U, Winterkamp S, Welte T, Kenn K:Noninvasive ventilation in pulmonary rehabilitation of COPD patients. Respir Med 2009; 103: 1329–36 CrossRef MEDLINE 13. Waschki B, Kirsten A, Holz O, et al.: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140: 331–42 CrossRef MEDLINE 14. Gloeckl R, Halle M, Kenn K: Interval versus continuous training in lung transplant candidates: arandomized trial. J Heart Lung Transplant 2012; 31: 934–41 CrossRef MEDLINE 15. Gloeckl R, Marinov B, Pitta F: Practical recommendations for exercise training in patients with COPD. Eur Respir Rev 2013; 22: 178–86 CrossRef MEDLINE 16. Liao WH, Chen JW, Chen X, et al.: Impact of resistance training in subjects with COPD: a systematic review and meta-analysis. Respir Care 2015; 60: 1130–45 CrossRef MEDLINE 17. Fisher J, Steele J, Bruce-Low S, Smith D: Evidence-based resistance training recommendations. Medicina Sportiva 2011; 15: 147–62 CrossRef 18. Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G: Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J 2011; 37: 416–25 CrossRef MEDLINE 19. Chen RC, Li XY, Guan LL, et al.: Effectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: a meta-analysis. Int J Chron Obstruct Pulmon Dis 2016; 11: 2965–7 CrossRef MEDLINE PubMed Central 20. Gloeckl R, Jarosch I, Bengsch U, et al.: What's the secret behind the benefits of whole-body vibration training in patients with COPD? A randomized, controlled trial. Respir Med 2017; 126: 17–24 CrossRef MEDLINE 21. Gloeckl R, Heinzelmann I, Baeuerle S, et al.: Effects of whole body vibration in patients with chronic obstructive pulmonary disease — a randomized controlled trial. Respir Med 2012; 106: 75–83 CrossRef CrossRef MEDLINE 22. Dhein Y, Munks-Lederer C, Worth H: Evaluation eines ambulanten strukturierten Schulungsprogramms fur Patienten mit COPD – eine Pilotstudie. Pneumologie 2003; 57: 591–7 CrossRef MEDLINE 23. Paone G, Serpilli M, Girardi E, et al.: The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate. J Rehabil Med 2008; 40: 672–7 CrossRef MEDLINE 24. Van Helvoort HA, Willems LM, Dekhuijzen PR, van Hees HW, Heijdra YF: Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study. NPJ Prim Care Respir Med 2016; 26: 16054 CrossRef MEDLINE PubMed Central 25. Bott J, Blumenthal S, Buxton M, et al.: Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 2009; 64 (Suppl. 1) : i1–51 CrossRef MEDLINE 26. Janssen DJ, Spruit MA, Leue C, et al.: Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis 2010; 7: 147–57 CrossRef MEDLINE 27. Lacasse Y, Rousseau L, Maltais F: Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001; 21: 80–6 CrossRef 28. Keil DC, Stenzel NM, Kuhl K, et al.: The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis 2014; 11: 31–40 CrossRef MEDLINE 29. Tselebis A, Bratis D, Pachi A, et al.: A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients. Multidiscip Respir Med 2013; 8: 41 CrossRef MEDLINE PubMed Central 30. Harrison SL, Greening NJ, Williams JE, Morgan MD, Steiner MC, Singh SJ: Have we underestimated the efficacy of pulmonary rehabilitation in improving mood? Respir Med 2012; 106: 838–44 CrossRef MEDLINE 31. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF: Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53–9 CrossRef 32. Ferreira IM, Brooks D, White J, Goldstein R: Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 12:CD000998 CrossRef 33. Abholz H, Gillissen A, Magnussen H, et al.: Nationale Versorgungsleitlinie COPD Version 1.9. Www.Leitlinien.De/nvl/copd 2012 (last accessed on 3 May 2017). 34. Cindy Ng LW, Mackney J, Jenkins S, Hill K: Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis 2012; 9: 17–26 CrossRef MEDLINE 35. Lahham A, McDonald CF, Holland AE: Exercise training alone or with the addition of activity counseling improves physical activity levels in COPD: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis 2016; 11: 3121–36 CrossRef MEDLINE PubMed Central 36. Breyer MK, Breyer-Kohansal R, Funk GC, et al.: Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res 2010; 11: 112 CrossRef MEDLINE PubMed Central 37. Glöckl R, Göhl O, Spielmanns M, et al.: Stellenwert ambulanter, gerätegestützter Trainingstherapie bei Atemwegs- und Lungenkrankheiten. Pneumologie 2016; 70: 446–53 CrossRef MEDLINE 38. Jany B: Klug entscheiden in der Pneumologie. Dtsch Arztebl 2016; 113: A-930 VOLLTEXT 39. Korczak D, Huber B, Steinhauser G, Dietl M: Versorgungssituation und Wirksamkeit der ambulanten im Vergleich mit der stationären pneumologischen Rehabilitation. DIMDI Schriftenreihe. Köln: Health Technology Assessment 2010. 40. Spruit MA, Augustin IM, Vanfleteren LE, et al.: Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J 2015; 46: 1625–35 CrossRef MEDLINE e1. Vanfleteren LE, Spruit MA, Groenen M, et al.: Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187:728–35 CrossRef MEDLINE

Enhancing Pulmonary Rehabilitation In COPD With Virtual Reality

Photo Credit: Freepik

The following is a summary of "Virtual reality for COPD exacerbation: A randomized controlled trial," published in the August 2024 issue of Pulmonology by Kizmaz et al.

Pulmonary rehabilitation (PR) is a well-established intervention for chronic obstructive pulmonary disease (COPD), yet managing chronic conditions like COPD, which necessitate ongoing treatment and are prone to exacerbations, often requires innovative motivational strategies. This study evaluated the impact of incorporating virtual reality (VR) into PR on symptoms, daily functioning, functional capacity, and psychological well-being in patients experiencing COPD exacerbations. 

About 50 patients hospitalized for COPD exacerbation were randomly assigned to two treatment groups. One group (n=25) engaged in traditional PR, which included daily pedaling exercises until discharge. The other group (n=25) participated in a similar PR regimen but with the addition of cycling simulation in a forest environment via VR (VR + PR). Both groups were assessed pre-and post-treatment using the 1-minute Sit-to-Stand test (STST), modified Medical Research Council (mMRC) scale, COPD Assessment Test (CAT), Hospital Anxiety and Depression Scale (HADS), and London Chest Activities of Daily Living (LCADL). Post-treatment, the STST improved in both groups, with the VR + PR group demonstrating a significantly more significant increase (p = 0.037). 

Both groups reported reductions in dyspnea levels and CAT scores, with the VR + PR group showing more pronounced improvements (p = 0.062 and p = 0.003, respectively). HADS scores also decreased in both groups, but the VR + PR group experienced a more significant reduction in depression and total scores (p < 0.05). Improvements in LCADL scores, excluding household activities, were observed in both groups, with more substantial gains in the VR + PR group (p < 0.05). These findings suggest that integrating virtual reality into pulmonary rehabilitation offers notable benefits for patients with COPD exacerbations, enhancing physical and psychological outcomes while demonstrating safety and efficacy.

Source: sciencedirect.Com/science/article/abs/pii/S0954611124001707


COPD Pulmonary Rehabilitation Rates Following Hospitalization Are Extremely Low

Following hospitalization for acute exacerbation of chronic obstructive pulmonary disease (AECOPD), pulmonary rehabilitation (PR) initiation rates are extremely low, according to study findings published in the Annals of the American Thoracic Society.

Investigators in Michigan assessed PR utilization following AECOPD hospitalization, with the goal of characterizing hospital-level variation in their state and identifying characteristics of high-performing hospitals.

The investigators conducted a retrospective study of patients with COPD hospitalization from January 2018 through December 2021. The study used claims data from the Michigan Value Collaborative (MVC), a Blue Cross Blue Shield of Michigan-funded quality initiative that includes over 100 acute care hospitals, as well as hospital data from the American Hospital Association annual survey to. Initiation of PR within 1 month of discharge was the primary outcome.

Overall, 99 hospitals and 36,389 patients were included in analysis. The majority of patients were White, women, older than 65 years of age, and Medicare fee-for-service insured.

"

Hospital-based strategies to improve PR utilization after discharge, adapted from those being successfully used with cardiac rehabilitation, should be further explored.

The investigators found that within 30 days following discharge, the rate of PR initiation across hospitals was less than 0.8%.

PR initiation by hospital ranged from 0.4% to 2.0%, adjusted. The investigators noted that compared with the set reference groups, being older than 85 years of age, in the 5th Distressed Community Index quintile (calculated from 7 components), and being a woman independently decreased the odds of PR initiation. Hospital level accounted for some variation in initiation rate, with 7% of variation attributable to the hospital after adjustments for hospital characteristics and patient case mix. The median relative odds between 2 randomly chosen hospitals was 1.6 for PR initiation.

Study limitations include the exclusion of Medicaid claims, owing to the generally younger age of Medicaid recipients. Also, the claims data did not include referral information, and given that, as study authors noted, fewer than 20%

of eligible patients are referred to PR, it is unclear whether the low utilization found in this study is due more to low enrollment participation vs low referral rates.

"PR initiation after hospitalization for acute COPD exacerbation is extremely low, with an overall initiation rate of <1% and adjusted initiation rates by hospital ranging from 0-4%," the investigators concluded. "Interventions targeted at patients alone are not

sufficient to improve utilization. Hospital-based strategies to improve PR utilization after discharge, adapted from those being successfully used with cardiac rehabilitation, should be further explored," the study authors noted.

Several study authors have received support, funding, or fees from government and industry sources. Please see reference for a complete list of disclosures.

This article originally appeared on Pulmonology Advisor






Comments

Popular Posts

Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University

Model Monday's: Diana Moldovan

“Live Coronavirus Map Used to Spread Malware - Krebs on Security” plus 1 more